Insight Molecular Diagnostics (IMDX) Capital Expenditures (QoQ) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Capital Expenditures (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 172.94 Mn | 144.01 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.55% |
| Dec 31, 2025 | 40.86% |
| Sep 30, 2025 | 200.86% |
| Jun 30, 2025 | 13.68% |
| Mar 31, 2025 | 43.46% |
| Dec 31, 2024 | 145.98% |
| Sep 30, 2024 | -54.45% |
| Jun 30, 2024 | 695.83% |
| Mar 31, 2024 | -90.91% |
| Dec 31, 2023 | 146.81% |
| Dec 31, 2022 | -6.64% |
| Sep 30, 2022 | -23.17% |
| Jun 30, 2022 | -28.38% |
| Mar 31, 2022 | 289.28% |
| Dec 31, 2021 | 1.78% |
| Sep 30, 2021 | -35.41% |
| Jun 30, 2021 | -27.55% |
| Mar 31, 2021 | 407.23% |
| Dec 31, 2020 | -68.44% |
| Sep 30, 2020 | 7.13% |